Azacitidine 100 mg/1 (Azacitidine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 100 mg/1

Azacitidine 100 mg/1 is a lyophilized powder for solution, used for specific medical conditions. This injection is administered intravenously or subcutaneously and is manufactured by Accord Healthcare Inc.

Strength

100 mg/1

Pack Size

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (16729-306-10)

Manufacturer / TM Owner

Accord Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Azacitidine 100 mg/1 is primarily used in the treatment of certain blood and bone marrow disorders. It works by affecting the growth of cancer cells, making it a key component in managing these conditions. Patients often wonder, 'What is Azacitidine used for?' and the answer lies in its ability to target abnormal cell growth.

Side Effects

Common effects of Azacitidine 100 mg/1 may include fatigue, nausea, and injection site reactions. Some individuals might experience fever or chills. These effects can vary widely among users, and it's important to monitor any changes in health while using this medication.

Precautions & Warnings

Azacitidine 100 mg/1 should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed guidelines for preparation and use. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

Azacitidine 100 mg/1 may interact with other medications, including those that affect the immune system or blood cell production. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of this drug.

Frequently Asked Questions

Azacitidine is used to treat certain blood and bone marrow disorders by affecting the growth of cancer cells.

Azacitidine 100 mg/1 is administered either intravenously or subcutaneously, depending on the patient's needs.

Common side effects may include fatigue, nausea, and reactions at the injection site.

Azacitidine may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

Azacitidine should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.